2009
DOI: 10.1007/s11926-009-0060-y
|View full text |Cite
|
Sign up to set email alerts
|

Hypocomplementemic urticarial vasculitis syndrome

Abstract: Hypocomplementemic urticarial vasculitis syndrome (HUVS) is an uncommon immune complex-mediated entity characterized by urticaria with persistent acquired hypocomplementemia. First described in 1973, HUVS is associated with several systemic findings including leukocytoclastic vasculitis, severe angioedema, laryngeal edema, pulmonary involvement, arthritis, arthralgia, glomerulonephritis, and uveitis. These manifestations should be present for at least 6 months. Laboratory findings include low complement levels… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
54
0
4

Year Published

2012
2012
2019
2019

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 74 publications
(58 citation statements)
references
References 39 publications
0
54
0
4
Order By: Relevance
“…These characteristics, including the extracutaneous and systemic involvement, are all uncommon for typical angioedema. The appropriate management is determined by the severity of the disease, and may include combinations of antihistamines, hydroxychloroquine, corticosteroids and immunosuppression [36]. …”
Section: Resultsmentioning
confidence: 99%
“…These characteristics, including the extracutaneous and systemic involvement, are all uncommon for typical angioedema. The appropriate management is determined by the severity of the disease, and may include combinations of antihistamines, hydroxychloroquine, corticosteroids and immunosuppression [36]. …”
Section: Resultsmentioning
confidence: 99%
“…Unfortunately, renal involvement can be more severe in children [22,30]. In fact, the biopsy findings in these patients are indistinguishable from SLE [31]. Lung involvement may be non-existent at the time of presentation.…”
Section: Discussionmentioning
confidence: 99%
“…The activation of this cascade causes mast cell degranulation and generates anaphylatoxins. In addition, it upregulates chemokines and cytokines, which lead to deposition of immune complexes, increased vascular permeability, chemotaxis of inflammatory cells, and exacerbate tissue destruction and edema [16]. These events cause the clinical findings of urticaria and or angioedema.…”
Section: Pathophysiologymentioning
confidence: 99%
“…The patients have been categorized into two subgroups: those with hypocomplementemia and those with normal complement levels [37][38][39]. Hypocomplementemic urticarial vasculitis syndrome is a rare entity associated with urticaria and persistent acquired hypocomplementemia.…”
Section: Hypocomplementemic Urticarial Vasculitis Syndromementioning
confidence: 99%
“…There are also systemic findings such as renal, pulmonary, gastrointestinal, neurologic, rheumatologic and ophthalmic. Treatment is determined by severity and systemic involvement of the disease, including systemic corticosteroids and immunosuppressants [37][38][39].…”
Section: Hypocomplementemic Urticarial Vasculitis Syndromementioning
confidence: 99%